Navigation Links
Managing Antibiotic-Resistant Bloodstream Infections with Rapid Molecular Diagnostics educational webinar hosted by Nanosphere and Xtalks

Northbrook, IL (PRWEB) July 18, 2013

NORTHBROOK, IL—July 18, 2013—Nanosphere, Inc. (NASDAQ: NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, together with Xtalks, will host an interactive webinar entitled: “Each Hour Counts: Improving Management of Carbapenem-Resistant Enterobacteriaceae (CRE) and Other Antibiotic-Resistant Bloodstream Infections with Rapid Molecular Diagnostics.” The complimentary webinar will be held on Wednesday, August 14, 2013 at 1:00pm EDT.

To register for this event, please visit:

Each year in the United States, there are more than 1.5 million hospital stays associated with bloodstream infections and septicemia, resulting in nearly 100,000 deaths and over $15 billion in healthcare costs [1].

Treatment of these serious bacterial infections in clinical practice is often complicated by antibiotic resistance, which has been associated with prolonged hospital stays, higher health care costs and increased mortality. The recent emergence of CREs is especially troubling, as there are very few antibiotic alternatives available to treat these bacteria.

In this webinar, Karen Carroll, M.D., Professor of Pathology and Medicine at Johns Hopkins University School of Medicine; Nathan Ledeboer, Ph.D., Assistant Professor of Pathology, Medical College of Wisconsin; and Debra Goff, PharmD, Clinical Associate Professor at The Ohio State University College of Pharmacy, will discuss strategies for managing antibiotic-resistant bacterial infections. These recognized leaders will review new molecular technologies that identify bacteria and corresponding antibiotic resistance more rapidly than traditional culture methods, and may enable earlier optimization of antibiotic therapy, thereby improving patient outcomes.

Registrants may qualify to receive a P.A.C.E. continuing education credit for this webinar.

About Xtalks
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

About Nanosphere, Inc.

Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for multiplexed infectious disease, genetic and ultra-sensitive protein testing. This easy-to-use platform offers laboratories a convenient, simple and cost-effective solution for highly sensitive nucleic acid and protein testing. Nanosphere’s product portfolio includes the Verigene Gram-Positive Blood Culture (BC-GP) (510(k) cleared; CE Mark) and Gram-Negative Blood Culture (BC-GN) (RUO; IUO; CE Mark) Tests. Nanosphere is based in Northbrook, IL.

For additional information regarding Nanosphere's infectious disease products, please contact Nanosphere at IDtesting(at)nanosphere(dot)us or visit


Roger Moody, Chief Financial Officer
Nanosphere, Inc.
+1 847-400-9021

Lindsey Saxon, Director of Communications
Nanosphere, Inc.
+1 847-400-9173

Karen Lim, Director of Member Services
+1 416-977-6555 ext 227

[1] Elixhauser, A. (Agency for Healthcare Research and Quality), Friedman, B. (Agency for Healthcare Research and Quality) and Stranges, E. (Thomson Reuters). Septicemia in U.S. Hospitals, 2009. HCUP Statistical Brief #122. October 2011. Agency for Healthcare Research and Quality, Rockville, MD.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Best Practices, LLC Issues New Report and Webinar on Managing Healthcare Reform through Effective Engagement with the Government Ecosystem
2. Effective Strategies for Managing Comparator Product Testing, New Webinar Hosted by Xtalks
3. New Advances and Opportunities in Managing Pain: Translational Animal Models, New Webinar Hosted by Xtalks
4. Trudeau Institute Awarded Grant to Investigate a New Approach to Treating Illnesses Caused by Weaponized and Antibiotic-Resistant Bacteria
5. Molecular Detection Inc. Further Strengthens Patent Portfolio Broadly Covering Detection of Antibiotic-Resistant Bacteria
6. Highest Genomic Replikin Counts Found in Antibiotic-Resistant Bacteria
7. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
8. New laboratory method uses mass spectrometry to rapidly detect staph infections
9. GeoVax Labs Presents New Findings on Potential HIV Vaccine at 2012 Conference on Retroviruses and Opportunistic Infections (CROI)
10. SRI International Researchers Developing Bioadhesive Gel to Protect Women from HIV and HSV Infections
11. Ondine Biomedical’s MRSAID(TM) Technology Demonstrates Successful Results in Reducing Surgical Site Infections
Post Your Comments:
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
(Date:11/25/2015)... 2015 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... fireside chat discussion at the Piper Jaffray 27th Annual ... The discussion is scheduled for Wednesday, December 2, at ... A replay will be available for 14 days after ... Julie NormartVP, Corporate Communications and Business Development , BrewLife(858) ...
(Date:11/24/2015)... 2015  Asia-Pacific (APAC) holds the third-largest share ... The trend of outsourcing to low-cost locations is ... volume share for the region in the short ... in the CRO industry will improve. ... ), finds that the market earned revenues ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
Breaking Biology Technology:
(Date:11/20/2015)... OXFORD, Connecticut , November 20, 2015 ... biometric authentication company focused on the growing mobile commerce ... its CEO, Gino Pereira , was recently interviewed ... The interview will air on this weekend on ... Bloomberg Latin America . --> NXTD ) ...
(Date:11/19/2015)... 19, 2015  Although some 350 companies are actively ... a few companies, according to Kalorama Information. These include Roche ... the market share of the 6.1 billion-dollar molecular testing ... Market for Molecular Diagnostic s .    ... still controlled by one company and only a handful ...
(Date:11/18/2015)... --> --> ... report titled  Gesture Recognition Market - Global Industry Analysis, ... to the report, the global gesture recognition market was valued at ... US$29.1 bn by 2021, at a CAGR of 20.3% ... dominated the global gesture recognition market in ...
Breaking Biology News(10 mins):